Janney Notes Strong Nucynta Rx Trends for March; Affirms DepoMed (DEPO) at 'Buy'

Go back to Janney Notes Strong Nucynta Rx Trends for March; Affirms DepoMed (DEPO) at 'Buy'

Form SC 13D/A DEPOMED INC Filed by: Starboard Value LP

April 12, 2016 5:27 PM EDT

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C.... More